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Background: Sarcoidosis is characterised by a T-lymphocytic alveolitis with a typically
increased T4/T8 ratio. The diagnostic value of this ratio is under debate.
Aim of the work: We prospectively evaluated the influence of BAL pre-lavage and the
impact of bronchial contamination on BAL differential cell count in 108 BAL specimens
obtained from patients with histologically confirmed sarcoidosis.
Methods: BAL was performed by instilling 150–300ml normal saline either in the middle
lobe or the lingula. Fifty-one patients (47%) underwent additional pre-lavage with 50ml
normal saline. Bronchial contamination was assessed by semi-quantitative analysis of
mucus, ciliated and squamous cells in the untreated BAL recovery.
Results: Pre-lavage did neither influence the lavage cellularity nor extend of contamina-
tion of the BAL. Content of mucus and ciliated cells, indicating bronchial contamination,
showed a high correlation (Kendal’s tau ¼ 0.61). Presence of either mucus or ciliated cells
in the BAL recovery was associated with a significant lower T4/T8 ratio (mucus: 4.9 vs. 8.0,
p ¼ 0.009; ciliated cells: 4.1 vs. 7.4, p ¼ 0.001). Squamous cells in the BAL recovery
representing oropharyngeal contamination did not significantly influence the T4/T8 ratio
(7.7 vs. 5.6, p ¼ 0.10).
Conclusion: Bronchial contamination of BAL as determined by the presence of mucus and
ciliated cells in the recovery decreases the T4/T8 ratio of BAL in sarcoidosis.
& 2007 Published by Elsevier Ltd.Published by Elsevier Ltd.
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Sarcoidosis is a multisystemic granulomatous disease of
unknown origin. The lung is involved in about 90% of patients
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F. Reichenberger et al.2026of all age groups, presenting with a lymphocytic alveolitis,
non-caseating granulomas, hilar adenopathy, pulmonary
fibrosis, and pulmonary infiltrates.1–4 Bronchoalveolar
lavage (BAL) cytology in sarcoidosis shows a characteristic
T-lymphocytic alveolitis with typically increased T4/T8
ratio.2,5 The T4 lymphocytes are predominantly of TH1
phenotype producing interferon gamma and interleukin 2.6
The higher the T4/T8 ratio the more it is specific for the
diagnosis of sarcoidosis.7,8 Its magnitude is influenced
neither by the radiological stage of the disease, by patients
race, gender, or age,9 nor by the amount of the lavage
volume.10 Nevertheless, the T4/T8 ratio shows a high
variability, and its diagnostic value for sarcoidosis is under
debate.8,9,11–14 In about 4–10% of cases, sarcoidosis present
with a T8 lymphocytic alveolitis and a low T4/T8 ratio. T8
lymphocytes have been shown to make important contribu-
tion to the inflammatory process in pulmonary sarcoido-
sis.15,16 Otherwise, the T4/T8 ratio has been regarded as
prognostic factor in pulmonary sarcoidosis.17,18
BAL cell count displays a picture of the momentary intra-
alveolar state, limiting the conclusions drawn from a single
lavage result.16,18,19 Non-resident alveolar cells including
lymphocytes are in a permanent kinetic state with alveolar
in- and efflux, proliferation, and apoptosis.19,20 In sarcoi-
dosis, alveolar cells show additional dynamics. Alveolar
lymphocyte accumulation in sarcoidosis might be due to an
enhanced mobility of lymphocytes, possibly mediated by
alveolar macrophages.21 While BAL cellularity shows inter-
lobar variation in interstitial lung diseases, the BAL cell
count is uniform in sarcoidosis throughout the lung.22
Besides technical processing of the lavage specimen,
analysis of the cellular content of BAL is influenced by the
quality of the obtained specimen.23–25 The degree of
extraalveolar contamination of the BAL can be assessed by
the presence of broncho-epithelial material, e.g. squamous
cells, ciliated cells, or mucopurulent exudates.22,25
Several techniques were introduced to improve the
quality and reliability of BAL results, e.g. separating the
first portion of the lavage to reduce the contamination of
BAL specimen, or filtration of BAL recovery prior to cellular
analysis.23 However, none of these techniques are generally
established in the clinical routine.
The present work prospectively evaluates the influence of
pre-lavage and the impact of BAL contamination on
differential cell count and lymphocyte subsets of the BAL
in patients with histologically proven sarcoidosis.Patients and methods
A total of 108 bronchoscopies with BAL were performed in
108 consecutive patients (56 male, 52 female) with
histologically proven sarcoidosis according to the guidelines
of the European Respiratory Society.23
Prior to the bronchoscopy, all patients received pre-
medication with intravenous atropine, hydrocodeine, and
midazolam, and inhalation of 4ml of 4% lignocaine solution.
Furthermore, 2% lignocaine was sprayed in the nasopharynx
and oropharynx (3–4 times each). During the procedure,
portions of 3ml of 1% lignocaine were instilled over the
vocal cords, in the trachea, and in both main bronchi,respectively. Another 3ml of 1% lignocaine was instilled in
the bronchus at the lavage site.
The bronchoscope was introduced transnasally or transo-
rally. After inspection of the tracheobronchial tree, the tip
of the bronchoscope was wedged in a subsegmental
bronchus either in the middle lobe or the lingula. For
performing BAL, the patient was brought in recline position,
and 150–300ml normal saline (NS) was instilled. Recovery
was obtained by gravity when using a BAL volume of
150–300ml or by gentle suction in BAL with a volume
between 150 and 240ml. The recovered fluid was collected
in ice cooled silicone tubes for further preparation. The
amount of the instilled lavage fluid and the recovered fluid
was recorded.
Patients were alternately assigned for a pre-lavage with
50ml NS prior to BAL in the same subsegmental bronchus.
Pre-lavage was performed by instillation of 50ml NS
recovered by gentle suction. The recovered fluid of the
pre-lavage has not been used for further cytological
analysis.
Preparation of BAL recovery for analysis was performed
using a standardised protocol. Briefly, the whole volume was
centifuged twice, and a differential cell count was
performed using a Neubauer-counting chamber. The follow-
ing parameters were used in the cellular analysis: total cell
count, percentage of macrophages, neutrophils, and lym-
phocytes. The sediment was divided, and one half was used
for two Papanicolaou- and two Giemsa-stained smears, and
one smear was stained for iron. The other half of the
sediment was diluted in 10% fetal calf serum (FCS) with
addition of 1ml of mucoliquifying agent (Mucolexx).
Cytospin specimens were prepared, air dried for 2 h at room
temperature and then fixed in acetone for 10min. The
cytospin specimens were sealed and stored in the freezer at
70 1C prior to immunocytochemistry. The alcaline phos-
phate (APAAP) technique was used for immunocytochemistry
according to a standarised protocol. Anti-human CD4 anti-
body was applied to detect T4 cells (DAKO, Clone MT319,
diluted at 1:20), and anti-human CD8 to detect T8 cells
(DAKO, Clone DK25, diluted at 1:40) on the same slide as
double immunostaining. Quantification of CD4 and CD8
positive cells was achieved by counting 2 100 cells each.
The T4/T8 ratio was calculated by dividing the number of
CD4 and CD8 positive cells.
Contamination of the BAL was assessed using three
criteria according to the literature.23,25 Content of mucus,
ciliated cells, and squamous cells were evaluated semi-
quantitatively by light microscopy. Results were divided into
four categories: 0 no, (+) little, + moderate, and ++ high
contamination. The category ‘‘little’’ was defined, when
mucus, ciliated cells, and squamous cells, respectively, were
present in less than 1/3 of the microscopic area, the
category ‘‘moderate’’ was used in cases with contamination
detectable in not more than 2/3 of the microscopic area,
and a ‘‘high’’classification was considered in situation with
contamination detectable in more than 2/3 of the micro-
scopic area.
Category ‘‘0’’ and ‘‘(+)’’ were classified as no contamina-
tion, whereas ‘‘+’’ and ‘‘++’’ were defined as present
contamination.
BAL differential cell count as well as degree of contam-
ination was assessed by two independent investigators (B.K.
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BAL quality in sarcoidosis 2027and B.B.). In dissimilar results, a final decision was made
upon a 3rd assessment (P.D. or L.B.).
Statistics
Computerised statistical analysis was performed using SPSS
version 8.0. and jmp statistics version 3.0. As the data were
normally distributed, McNemar’s test for correlation of
paired data, Pearson correlation coefficient, Students t-
test, and Chi-square test were used. For multivariate
analyses, ANOVA were used including correction according
to Bonferroni. Data are shown as mean (SD).
Results
A mean of 243 (64)ml NS was instilled. The mean fluid
recovery was 137 (61)ml (55 (17)%, respectively). Cellular
analysis showed a total cell count of 233 (184) 106 l1 with
a percentage of 61 (21)% macrophages, 35 (21)% lympho-
cytes, 3 (4)% neutrophils, and 0.6 (1)% eosinophils. Analysis
of lymphocyte subsets showed 68 (18)% CD4 positive (T4)
and 19 (15)% CD8 positive (T8) cells, corresponding to a T4/
T8 ratio of 6.5 (6.0) (Table 1). There was no gender
associated difference in differential cell count and count
of lymphocyte subsets.
In 51 patients (47%), a pre-lavage was performed,
whereas 57 patients did not receive a pre-lavage. This
inhomogeneous distribution is caused by six patients
assigned to the pre-lavage group, in whom the diagnosis of
sarcoidosis has not been confirmed.
Performance of a pre-lavage did neither influence
the differential cell count nor the contamination of BAL
(Table 1).
The BAL recovery was similar in patients undergoing a BAL
with 250–300ml (59713%) compared to patient, in whom a
BAL with 150–250ml was performed (55711%) (p ¼ 0.06).
There were no correlations between instilled lavage volume
and total cell count (r ¼ 0.14), lymphocyte count
(r ¼ 0.04) or CD4/CD ratio (r ¼ 0.14), respectively.
Assessing different contamination parameters, mucus and
ciliated cells showed a high correlation (Kendal’s tau ¼ 0.61),Table 1 Pre-lavage does not influence BAL quality and differe
Total (n ¼ 108) With pre
Total cell count (106 l1) 233 (184) 236 (203
Macrophages (%) 61 (21) 63 (19)
Neutrophils (%) 3 (4) 4 (5)
Lymphocytes (%) 35 (21) 32 (19)
T4+ (%) 68 (18) 66 (18)
T8+ (%) 19 (15) 18 (13)
T4/T8 ratio 6.5 (6.0) 6.3 (5.9)
BAL recovery (%) 55 (16) 57 (17)
Mucus (yes/no) 54/54 28/23
Squamous cells (yes/no) 66/42 31/20
Ciliated cells (yes/no) 36/72 14/37
n.s.: not significant.
Chi-square test.whereas squamous cells did not correlate to ciliated cells
and mucus material, respectively (Kendal’s tau ¼ 0.26
each).
We analysed the cellularity and the degree of contamina-
tion in respect to the BAL recovery in absolute (volume of
returned fluid) and relative (% from the instilled lavage
volume) values. There were no correlations between
recovery and total cell count (absolute r ¼ 0.14; relative
r ¼ 0.12), lymphocyte count (absolute r ¼ 0.07; relative
r ¼ 0.131), or CD4/CD ratio (absolute r ¼ 0.1; relative
r ¼ 0.04), respectively.
However, absolute and relative BAL recovery volume was
significantly lower in samples with a high degree of
contamination with mucus (ANOVA, po0.005), bronchial
cells (ANOVA, po0.01), or squamous cells (ANOVA,
p ¼ 0.01). The cellular content of BAL was analysed in
respect to the distinct contamination parameters. In the
presence of squamous cells, the neutrophil count was
slightly but significantly increased (p ¼ 0.04), in contrast
to other cell types (Table 2). When mucus was present in the
BAL, the T4 cell count and the T4/T8 ratio were significantly
decreased (po0.03 and p ¼ 0.005, respectively; Table 3).
BAL recovery contamination with ciliated cells was signifi-
cantly associated with a decreased T4/T8 ratio (p ¼ 0.002)
due to a lower T4 cell count (p ¼ 0.05), and a slightly
increased neutrophil count (p ¼ 0.02; Table 4).
The influence of mucus or ciliated cell contamination on
T4/T8 ratio was not influenced by the performance of pre-
lavage.Discussion
BAL cellularity has an important impact on physicians
diagnostic judgement in assessing interstitial lung disease.26
The presence of BAL lymphocytosis and the analysis of
lymphocyte subsets are of particular interest in sarcoido-
sis.27,28
The present study shows the influence of BAL contamina-
tion on the BAL cellularity in sarcoidosis. Bronchial
contamination is best represented by the presence of
mucus and ciliated cells, respectively, showing a strongntial cell counts in sarcoidosis (mean (SD)).
-lavage (n ¼ 51) No pre-lavage (n ¼ 57)
) 229 (166) 0.86
60 (23) 0.37
3 (3) 0.37
37 (22) 0.22
71 (18) 0.20
19 (16) 0.63
6.6 (6.0) 0.79
53 (16) 0.22
26/31 n.s.
35/22 n.s.
20/37 n.s.
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Table 3 Influence of mucus on BAL differential cell counts (mean (SD)).
No mucus (n ¼ 54) Mucus positive (n ¼ 54) p
Total cell count (106 l1) 243 (202) 222 (165) 0.57
Macrophages (%) 60 (22) 62 (20) 0.57
Neutrophils (%) 3 (3) 4 (5) 0.03
Lymphocytes (%) 37 (22) 33 (20) 0.30
T4+ (%) 72 (16) 64 (20) 0.03
T8+ (%) 17 (13) 21 (16) 0.18
T4/ T8 ratio 8.0 (7.2) 4.9 (3.8) 0.009
BAL recovery (%) 58 (16) 52 (16) 0.06
Ciliated cells (yes/no) 4/50 31/23 o0.001
Chi-square test.
Table 2 Influence of squamous cells on differential cell counts in BAL (mean (SD)).
No squamous cells (n ¼ 42) Squamous cells (n ¼ 66) p
Total cell count (106 l1) 205 (112) 251 (217) 0.15
Macrophages (%) 65 (20) 59 (21) 0.16
Neutrophils (%) 2 (3) 4 (4) 0.03
Lymphocytes (%) 33 (20) 36 (21) 0.39
T4+ (%) 70 (18) 67 (19) 0.31
T8+ (%) 16 (11) 21 (17) 0.12
T4/T8 ratio 7.7 (6.7) 5.6 (5.2) 0.10
BAL recovery (%) 60 (16) 52 (16) 0.01
Ciliated cells (yes/no) 6/36 29/37 o0.01
Mucus (yes/no) 16/26 38/28 n.s.
Chi-square test.
Table 4 Influence of ciliated cells on BAL differential cell counts (mean (SD)).
No ciliated cells (n ¼ 73) With ciliated cells (n ¼ 35) p
Total cell count (106 l1) 233 (186) 232 (182) 0.99
Macrophages (%) 60 (21) 64 (20) 0.33
Neutrophils (%) 3 (3) 5 (5) 0.03
Lymphocytes (%) 37 (21) 31 (20) 0.14
T4+ (%) 70 (18) 63 (19) 0.08
T8+ (%) 17 (15) 22 (14) 0.11
T4/T8 ratio 7.4 (6.5) 4.1 (3.3) 0.001
BAL recovery (%) 59 (15) 56 (16) 0.19
F. Reichenberger et al.2028correlation. Squamous cells in the BAL recovery might be
merely due to upper airway contamination.4
Separation of the first aliquot of the lavage as ‘‘pre-
lavage’’ with 50ml NS did neither influence the amount of
bronchial contamination nor the cellular composition of
recovered BAL. Therefore, we could not confirm the
usefulness of the separation of the first lavage aliquot
as recommended by others,24 and based on our experi-
ence we stopped to perform pre-lavage in our
institution.Bronchial contamination of BAL did significantly influence
the T4/T8 ratio. We found a significantly lower T4/T8 ratio
in BAL specimen with a high degree of bronchial contamina-
tion as displayed by content of mucus and ciliated cells.
Therefore, we regard the assessment of contamination
important for evaluation of BAL results. As filtration of the
BAL recovery removes contamination, it should be
considered not to filter the whole lavage specimen in
sarcoidosis. This has been previously proposed in bronchial
asthma.29
ARTICLE IN PRESS
BAL quality in sarcoidosis 2029BAL cellular analysis is dependent on the quality of the
obtained lavage specimen. In our study, the degree of
contamination was higher when only a small BAL recovery
could be retrieved. This supports previous findings that an
appropriate lavage specimen should be recovered.23,30
BAL cellularity is influenced by the technical preparation
of BAL recovery. When using cytocentrifugation, counting in
a circular pattern around the centre area is required, as
cells and especially lymphocytes might not equally distri-
bute over the cytocentrifuged spot.24,31 This factor can be
eliminated by using a standardised protocol as in our study.
The technique of cellular analysis itself, either immunos-
taining of FACS-based analysis seems not to influence the
cellular analysis.32,33
Previous studies have proposed the value of induced
sputum cytology in sarcoidosis; however, the results are
varying between different investigators.34,35 One study
showed a lower lymphocyte count when induced sputum
was contaminated by the bronchial and oropharyngeal
compartment, indicating that the issue of contamination
needs to be taken into account also when using different
techniques for assessment of alveolar cellularity.34
About 4–10% of patients with pulmonary sarcoidosis
present with a T8 lymphocytic alveolitis. It remains
speculative, if some of our patients may have a low T4/T8
ratio due to a T8 alveolitis. However, the lower T4/T8 ratio
was merely due to a lower T4 cell count rather than
increased T8 lymphocytes. Furthermore, the incidence of
4–10% T8 lymphocytic alveolitis would potentially affect less
than 10 BAL in our study.11,15,16
There are several limitations of our study that need to be
addressed. Firstly, BAL was performed with a wide range of
infusion fluid. The amount of fluid was individually deter-
mined during the investigation. Secondly, the BAL differ-
ential cell count has not been counter-checked by another
method, e.g. FACS-analysis. However, we used a standar-
dised protocol for cellular analysis and immunostaining,
which might minimise the risk of error. Nevertheless, we
included all patients with sarcoidosis assessed at our
institution in the investigation to avoid selection bias.
In conclusion, in sarcoidosis the T4/T8 ratio of BAL is
significantly influenced by bronchial contamination, repre-
sented by the presence of mucus and ciliated cells in the
lavage recovery. Bronchial contamination needs to be
considered when interpreting BAL results.References
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